Latest News about NVS
Recent news which mentions NVS
   EMA's Advisory Committee Backs Approval Of Incyte's Capmatinib In Advanced Lung Cancer Setting
   
  
  
  April 22, 2022
  From Benzinga
 
   FDA Puts Blood Cancer Nods Under Scrutiny On Substantial Toxicity Profile Of PI3K Drugs
   
  
  
  April 21, 2022
  From Benzinga
 
   7 Potential Biotech Stocks Buyout Targets in 2022
   
  
  
  April 21, 2022
  From InvestorPlace
 
   3 Fantastic Biotech Stocks to Buy in April
   
  
  
  April 18, 2022
  From Motley Fool
 
   2 Unstoppable Green Flags for AbbVie
   
  
  
  April 14, 2022
  From Motley Fool
 
   Biogen’s Aduhelm Crashes the Biotech Sector
   
  
  
  April 13, 2022
  From InvestorPlace
 From Benzinga
 
   Attacking Diseases On Multiple Fronts — Pharmaceutical Development Combined With Cannabis?
   
  
  
  April 12, 2022
  From Benzinga
 
   Overview Of Value Stocks In The Healthcare Sector
   
  
  
  April 11, 2022
  From Benzinga
 
   The Week Ahead In Biotech (April 10-April 16): Regeneron FDA Decision, Cancer Conference Presentations And More
   
  
  
  April 10, 2022
  From Benzinga
 
   3 Things About Pfizer That Smart Investors Know
   
  
  
  April 08, 2022
  From Motley Fool
 From InvestorPlace
 From Benzinga
 
   Novartis Highlights Four-Year Efficacy, Safety Data On Kesimpta In Multiple Sclerosis
   
  April 05, 2022
  Tickers 
   NVS
  
  
  From Benzinga
 From Benzinga
 
   7 Biotech Stocks to Buy With Key Catalysts for April
   
  
  
  April 05, 2022
  From InvestorPlace
 From Benzinga
 
   Novartis To Strengthen Pipeline, Boost Productivity With New Organizational Structure
   
  April 04, 2022
  Tickers 
   NVS
  
  
  From Benzinga
 
   3 CEOs to Invest In
   
  
  
  April 01, 2022
  From Motley Fool
 From Benzinga
 
   Which Chinese Stocks Will Be Delisted? 8 in U.S. Crosshairs
   
  
  
  March 28, 2022
  From InvestorPlace
 From Benzinga
 From Motley Fool
 
   Novartis Receives Positive CHMP Opinion For Kymriah In Follicular Lymphoma, Jakavi In GvHD
   
  March 25, 2022
  Tickers 
   NVS
  
  
  From Benzinga
 
   2 Healthcare Stocks You Can Buy and Hold for the Next Decade
   
  
  
  March 24, 2022
  From Motley Fool
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
